Head-to-head · computed 2026-08-11
Gala GLP-1 vs Hims & Hers
Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149. Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
Tirzepatide
| Gala GLP-1 | Hims & Hers | |
|---|---|---|
| All-in maintenance | $179/mo | $548/mo |
| Best plan rate | $179/mo | $548/mo |
| 12-month total | $2,148 | $6,576 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Hims & Hers's $548 by $369 a month at the 10 mg/wk maintenance basis — $4,428 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's tirzepatide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. Hims & Hers's runs $548 a month billed monthly. On the twelve-month basis Gala GLP-1's $2,148 beats Hims & Hers's $6,576 by $4,428 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Gala GLP-1 | Hims & Hers | |
|---|---|---|
| All-in maintenance | $179/mo | $453/mo |
| Best plan rate | $179/mo | $453/mo |
| 12-month total | $2,148 | $5,436 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Hims & Hers's $453 by $274 a month at the 2.4 mg/wk maintenance basis — $3,288 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's semaglutide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. Hims & Hers's runs $453 a month billed monthly. On the twelve-month basis Gala GLP-1's $2,148 beats Hims & Hers's $5,436 by $3,288 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
Gala GLP-1 carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Gala GLP-1 is dose-flat — the price survives titration — while Hims & Hers's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
What our desk is watching on each
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Questions people ask
Is Gala GLP-1 or Hims & Hers cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Gala GLP-1 vs Hims & Hers miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Gala GLP-1 and Hims & Hers cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Gala GLP-1 and $6,576 at Hims & Hers — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Gala GLP-1 · Hims & Hers. Official sites: Gala GLP-1 ↗ · Hims & Hers ↗. Nothing here is medical advice.